Chemical Name: Isoproterenol Hydrochloride
Common Synonyms: Isoprenaline hydrochloride
CAS Number: 51-30-9
Appearance: Fine, white to off-white crystalline powder
Odor: Nearly odorless
Primary Use: Typically found in medical settings as a bronchodilator and cardiac stimulant, this substance carries a history in emergency medicine for managing certain types of bradycardia and heart block.
Hazard Classification: Can cause respiratory, eye, and skin irritation. Overexposure might trigger symptoms such as rapid heartbeat or tremors given its potent pharmacological properties.
Main Hazards: Noted for its cardiovascular effects at low doses, so accidental ingestion, inhalation, or skin contact should be avoided during handling.
Acute Effects: Symptoms include headache, dizziness, restlessness, and palpitations.
Chronic Effects: Prolonged or repeated exposure risk remains rare in non-clinical settings but could theoretically contribute to sensitization or exacerbation of existing heart conditions.
Active Component: Isoproterenol hydrochloride, purity typically exceeds 98 percent.
Impurities: Trace byproducts from synthesis or degradation, investigated during quality control to keep impurity levels low.
Formulation: Sometimes handled as a pure standard in research labs, or mixed as a solution for clinical use.
Eye Contact: Immediately rinse eyes using plenty of water and avoid rubbing.
Skin Contact: Wash affected area with soap and water; remove contaminated clothing promptly and wash before reuse.
Inhalation: Move into fresh air without delay; monitor for signs of respiratory distress or abnormal heart rhythm.
Ingestion: Seek prompt medical attention; never induce vomiting.
Medical Attention: Medical personnel should be prepared for potential cardiovascular complications since overdoses can lead to potentially life-threatening arrhythmias.
Suitable Extinguishing Media: Water spray, dry chemical powder, foam, or carbon dioxide.
Hazardous Combustion Products: May emit toxic fumes of carbon monoxide, carbon dioxide, and nitrogen oxides during combustion.
Protective Equipment: Firefighters need self-contained breathing apparatus and full chemical protective clothing.
Firefighting Procedures: Contain run-off water to prevent environmental contamination as much as possible.
Personal Precautions: Wear protective gloves, laboratory coat, and eye protection; avoid dust formation.
Environmental Precautions: Prevent entry into drains or waterways; sweep up residual powder using specialized vacuum or shovel without dust generation.
Clean-Up Method: Place collected material into proper waste container for approved disposal.
Handling: Manipulate in a well-ventilated zone using personal protective gear. Avoid contact with eyes and skin. Minimize generation of dust. Maintain awareness of the compound's potent activity on the cardiovascular system.
Storage: Store in tightly sealed containers away from direct heat or sunlight. Must be kept in a dry, cool environment to slow decomposition.
Incompatibilities: Strong oxidizing agents and acids should not be stored in proximity.
Engineering Controls: Fume hood or local exhaust ventilation.
Respiratory Protection: Use a dust mask or respirator under conditions of potential exposure above recommended limits.
Skin Protection: Chemical-resistant gloves and protective clothing are standard; avoid skin contact.
Eye Protection: Safety glasses with side-shields.
Work Practices: Wash hands thoroughly after use; never eat, drink, or smoke in areas where this substance is handled.
Physical State: Solid
Color: White or off-white powder
Odor: Practically odorless
pH (solution): Ranges from 3.0 to 5.0 for aqueous solution
Melting Point: Between 169°C to 172°C
Solubility: Freely soluble in water, less so in alcohol
Other Properties: Stable under ordinary conditions but sensitive to light and moisture; may discolor on prolonged exposure.
Chemical Stability: Remains stable when dry and shielded from light. Humid conditions or exposure to air increase risk of breakdown.
Reactivity: No violent reactivity under normal handling. Can degrade with strong acids, bases, or oxidizers.
Decomposition Products: Produces hazardous gases like nitrogen oxides and carbon monoxide if burning or breaking down at high temperature.
Main Routes of Exposure: Inhalation, ingestion, and skin contact.
Acute Toxicity: Short-term exposure causes rapid heart rate, palpitations, tremor, or headache.
Chronic Toxicity: Rare with routine handling, but existing data highlights potential cardiac overstimulation and arrhythmias with significant, repeated exposure.
Sensitization Risk: Repeated or prolonged contact might induce allergy in sensitive persons. Most individuals experience effects only with significant exposure.
Carcinogenicity: No substantial evidence suggests a link to cancer.
Aquatic Toxicity: Limited environmental data exists, but pharmaceuticals like this can stress aquatic life where disposal is uncontrolled.
Persistence: Rapid breakdown in well-managed settings; persistent in cold or contained environments.
Bioaccumulation: Expected to be low, but waste pharmaceutical pollution remains a concern for downstream environments.
Wastewater: Professional disposal protects local waterways.
Waste Management: Incineration in a licensed facility or chemical landfill as per local guidelines.
Avoid Drain Disposal: Disposal via sink or toilet risks pharmaceutical residues entering the environment.
Contaminated Packaging: Treat as hazardous waste; thoroughly rinse if allowed and recycle or dispose according to regulations.
Local Regulations: Always consult national or regional waste authorities for current procedures.
Packing: Secured in sealed, clearly labeled packaging to avoid leaks.
Transport Hazards: Minimal under correct packaging, but significant spills may trigger emergency response due to toxicity risk.
Accidental Spillage: Immediate containment and reporting protect both handlers and the surrounding environment.
Handling Guidelines: Subject to pharmaceutical control and workplace safety standards worldwide.
Environmental Legislation: Increasing global attention to pharmaceutical residues in water highlights the need for careful end-of-life management.
Workplace Safety: Workers handling the compound receive specific hazard communication training and access to information about the risks involved.